Loading the records…
Loading the records…
Veterans Affairs · 257-NETWORK CONTRACT OFFICE 17 (36C257)
Veterans Affairs is planning to buy "New - Decipher Contract Base +4". This is an early notice: it is not taking bids yet. The original due date (May 11, 2026) has passed; check the latest amendment for the current one. In the last 2 years, similar work went to 6 companies, usually for about $3.0M per award. An award could come any day: the usual time to award has passed.
Put together from the facts on this page; the details and sources are below.
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Every notice posted under solicitation 36C25726Q0509 in this department, oldest first.
Standard steps for the notice type; not advice about this buyer.
tion 0001 Provide sendout reference laboratory testing not performed in-house at VANTHCS' Pathology & Laboratory Medicine Service Lab. Test will encompass all CPT codes. Contractor will provide all labor, supplies, equipment, insurance, and supervision to provide the items. Items are to be ordered on an as needed basis exact quantities of each item cannot be determined in advance as they are based upon physician's orders. This test provides prognostic information to help guide and personalize the treatment of prostate cancer. Test predicts 5yr Metastasis and 10yr cancer-related mortality in localized prostate cancer. Total annual estimated test volume is 15. The proposed sole source procurement will be made by a pricing agreement with Decipher Corp., based upon pricing from previous contracts. The requesting activity states the off-site testing agreement is for genomic prostate cancer testing; required for the testing of post-surgery oncology patients. The sole source justification request submitted by the requesting activity stated that a sole source is required because they require genomic prostate cancer testing for patients who have previously undergone surgery to determine the likelihood of the cancer reoccurrence. This notice is not to be considered a request for quotations or proposals. A contract will not be awarded based on an offer received in response to this notice; however, all responsible sources may submit a capability statement, proposal or quotation, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the government. If no affirmative written response is received within five (5) days from the publication of this notice, a contract will be issued to Decipher Corp., without any further notice. The anticipated statutory authority permitting other than full and open competition for the requirement is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services will Satisfy Agency Needs. All responsible sources that feel they should be considered qualified to provide the above-mentioned products may submit a response to this notice (by the response due date shown above) to Susan.Flores2@va.gov. The information provided shall include detailed (and relevant) documentation to allow the government to perform adequate market research and make a proper determination. A determination by the government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. THIS IS NOT A REQUEST FOR COMPETITIVE PROPOSALS. THERE IS NO SOLICITATION AVAILABLE AT THIS TIME. REQUESTS FOR A SOLICITATION WILL NOT RECEIVE A RESPONSE.
16 award notices on SAM.gov in the last 24 months. Matched by: Same office (257-NETWORK CONTRACT OFFICE 17 (36C257)), same product/service code (PSC) Q301 and NAICS 621511.
Single-winner award sizes (16): middle half $1.4M to $6.5M, median $3.0M; range $62K to $17.0M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| QUEST DIAGNOSTICS INCORPORATED · $DGX · $11.8B | 8 | $49.6M | Mar 3, 2026 |
| LABORATORY CORPORATION | 4 | $22.7M | Apr 27, 2026 |
| PROPATH SERVICES, LLC | 1 | $4.0M | Jun 11, 2026 |
| BEXAR COUNTY HOSPITAL DISTRICT SAN ANTONIO 78229 | 1 | $2.6M | Nov 20, 2024 |
| ARUP LABORATORIES INC | 1 | $450K | Mar 19, 2025 |
| AMBRY GENETICS CORPORATION | 1 | $62K | Feb 26, 2026 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
One award's total value against one year of revenue; many awards are paid over several years.
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
For the 6 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.